Pearl Raises Largest-Ever Investment in Dental AI with $58 Million Round
24 July 2024 - 11:30PM
Business Wire
The landmark investment in dental artificial
intelligence enables Pearl to further expand its dental AI
solutions and meaningfully improve oral health outcomes for
patients
Pearl, the global leader in dental AI, today announced that it
has raised $58 million in Series B funding to accelerate its
mission to elevate patient care in dentistry. Left Lane Capital led
the round, with participation from Smash Capital, Alpha Partners,
and existing investors, Craft Ventures and Neotribe Ventures. This
funding marks the largest investment ever in dental artificial
intelligence.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240724200226/en/
Pearl, the global leader in dental AI,
today announced that it has raised $58 million in Series B funding
to accelerate its mission to elevate patient care in dentistry.
(Photo: Business Wire)
With this investment, Pearl will continue to advance innovation
in technologies that enhance the health of dental patients around
the world by expanding its line of dental AI products, broadening
its regulatory and patent portfolio, and increasing global access
to the transformative benefits of AI in dentistry. At present,
Pearl’s machine learning and computer vision tools solve a core
challenge in dentistry: inconsistency in diagnostic accuracy, which
directly impacts the quality of patient care. The company’s AI
serves as a real-time aid to help dentists read patient x-rays,
deliver consistent, objective, and accurate diagnoses, and clearly
communicate findings to patients with precision, clarity, and
confidence.
Since receiving the first-ever FDA clearance for AI software to
help dental professionals detect multiple different pathologies and
other conditions in x-rays, Pearl’s clinical AI has gained
regulatory authorizations for chairside use in over 120 countries
and recognition among TIME’s Best Inventions. The company plans to
use the funding announced today both to accelerate ongoing
development of computer vision capabilities – including detection
and tracking of disease in 3D and other imaging modalities – and
introduce new AI tools to improve patient treatment planning,
insurance claim approvals and dental education.
“In the field of healthcare, dentistry has become an AI
standard-bearer, demonstrating the technology’s enormous utility
and benefit in day-to-day patient care––and Pearl has led the AI
charge in dentistry,” said Ophir Tanz, founder and CEO of Pearl.
“This historic funding round underscores the impact of Pearl’s
capabilities and supports our belief that high-quality, AI-powered
dental care should be accessible to everyone. With this investment,
Pearl will continue to push the envelope, providing pioneering
machine learning to improve oral health outcomes and strengthen
trust between the patient and dental professionals.”
This investment follows a period of significant growth for
Pearl. The company grew its revenue by 458% in 2023 and remains the
only dental AI company with a global market presence. Pearl’s
technology is used in dental practices across six continents and is
commercially available to over 500,000 dental practices and
millions of dental professionals worldwide. The company has also
integrated its AI into dozens of popular imaging and practice
management systems and is the preferred radiologic AI provider for
leading dental technology distributors.
“We have spent the past year evaluating this market and it is
clear that Pearl stands above peers at the forefront of dental
innovation,” said Vinny Pujji, Managing Partner at Left Lane
Capital. “Pearl’s pioneering dental Al improves diagnostic accuracy
and efficiency while transforming the provider-patient
relationship. We’re confident in Pearl’s ability to continue
setting new standards of care and are thrilled to support their
next phase of growth.”
Pearl’s AI technology offers a seamless and less invasive
approach to dental diagnostics. By accurately detecting disease and
displaying clinical findings that are easy for patients to
understand, the company’s FDA-cleared software enhances the
efficiency, consistency, and precision of radiologic exams, while
also facilitating patient education and engagement in their dental
health. Leveraging its new funding, Pearl will enable dental
professionals to continually raise the standard of care with more
transparent, accurate and objective diagnoses, more effective
individualized care, and deeper patient trust in dentistry.
For more information on how Pearl’s suite of solutions can
enhance your dental practice, visit hellopearl.com.
About Pearl
Pearl is an AI-driven company committed to enhancing patient
care in dentistry. Founded in 2019 by a team with decades of
experience developing successful, enterprise-grade computer vision
solutions, Pearl introduced the first-ever FDA-cleared AI capable
of reading and instantly identifying diseases in dental x-rays.
With regulatory clearance in 120 countries, Pearl’s AI assists
dentists in making precise clinical decisions and effectively
communicating with patients, thereby transforming the dental care
experience worldwide. As dentistry’s global AI leader, Pearl is
committed to the ongoing innovation of robust, accessible AI tools
that improve patient health outcomes and build greater trust in
dental medicine. To request a demo, please visit
hellopearl.com/getdemo.
About Left Lane Capital
Founded in 2019, Left Lane Capital is a New York and
London-based global venture capital and growth equity firm
investing in internet and technology companies with a consumer
orientation. Left Lane’s mission is to partner with extraordinary
entrepreneurs who create category-defining companies across growth
sectors of the economy, including software, healthcare, e-commerce,
consumer, fintech, medtech, and other industries. Select
investments include Bilt Rewards, Polycam, Kings League, M1
Finance, Wayflyer, Masterworks, Blank Street, Talkiatry, LemFi, and
more. For more information, please visit www.leftlane.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240724200226/en/
Megan Cahalan Matter Health for Pearl Pearl@matternow.com